Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Ocular Therapeutix ( (OCUL) ) is now available.
Ocular Therapeutix, Inc. has recently expanded its 2019 Inducement Stock Incentive Plan, enabling the issuance of an increased number of shares to motivate and retain employees. The amendment, adopted by the board on October 4, 2024, ups the total available shares from 4,804,000 to 6,054,000, demonstrating the company’s commitment to leveraging stock-based incentives to drive growth and success.
Find detailed analytics on OCUL stock on TipRanks’ Stock Analysis page.
